A survey of patients with cancer and oncology health-care professionals about cannabis use during treatment.

Richard T Lee, Elyssa Kim, Prateek Mendiratta, Megan Farrell, Shalena Finklea, Lauren Huang, Erika Trapl, Stanton Gerson, Jennifer Cullen
{"title":"A survey of patients with cancer and oncology health-care professionals about cannabis use during treatment.","authors":"Richard T Lee, Elyssa Kim, Prateek Mendiratta, Megan Farrell, Shalena Finklea, Lauren Huang, Erika Trapl, Stanton Gerson, Jennifer Cullen","doi":"10.1093/jncimonographs/lgae007","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>This study characterizes patient and health-care professional perspectives regarding medical cannabis use at a National Cancer Institute-Designated Cancer Center. Data evaluated included the prevalence and patterns of and reasons for cannabis use.</p><p><strong>Methods: </strong>Patients with cancer undergoing treatment were recruited into a cross-sectional survey as part of a national National Cancer Institute-funded effort. Participants completed a survey about cannabis use, reasons for use, and types of cannabis. A health-care professional survey was also conducted to explore perspectives regarding patients' use of cannabis.</p><p><strong>Results: </strong>A total of 313 patients with cancer (mean [SD] age = 60.7 [12.8] years) completed the survey (43% response rate) between 2021 and 2022. Of the respondents, 58% were female; identified as White (61%) and Black (23%); and had diverse cancer diagnoses. Nearly half of respondents (43%) had previously used cannabis, one-quarter (26%) had used cannabis since their cancer diagnosis, and almost 1 in 6 (17%) were actively using cannabis at the time of survey completion. The most common modes of ingestion were gummies (33%) and smoking (30%). The most commonly reported reasons for use were insomnia (46%), pain (41%), and mood (39%). For the 164 health-care professionals who completed the survey (25% response rate), the majority agreed that cannabis use (72%) is safe and beneficial for patients (57%). Four in 10 (39%) health-care professionals felt comfortable providing guidance to patients about cannabis use; however, only 1 in 8 (13%) felt knowledgeable about the topic of cannabis.</p><p><strong>Conclusions: </strong>Approximately one-sixth of patients with cancer receiving treatment actively use cannabis for management of various cancer symptoms. Perceptions about cannabis use and education varied widely among health-care professionals.</p>","PeriodicalId":73988,"journal":{"name":"Journal of the National Cancer Institute. Monographs","volume":"2024 66","pages":"290-297"},"PeriodicalIF":0.0000,"publicationDate":"2024-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11303858/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the National Cancer Institute. Monographs","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/jncimonographs/lgae007","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: This study characterizes patient and health-care professional perspectives regarding medical cannabis use at a National Cancer Institute-Designated Cancer Center. Data evaluated included the prevalence and patterns of and reasons for cannabis use.

Methods: Patients with cancer undergoing treatment were recruited into a cross-sectional survey as part of a national National Cancer Institute-funded effort. Participants completed a survey about cannabis use, reasons for use, and types of cannabis. A health-care professional survey was also conducted to explore perspectives regarding patients' use of cannabis.

Results: A total of 313 patients with cancer (mean [SD] age = 60.7 [12.8] years) completed the survey (43% response rate) between 2021 and 2022. Of the respondents, 58% were female; identified as White (61%) and Black (23%); and had diverse cancer diagnoses. Nearly half of respondents (43%) had previously used cannabis, one-quarter (26%) had used cannabis since their cancer diagnosis, and almost 1 in 6 (17%) were actively using cannabis at the time of survey completion. The most common modes of ingestion were gummies (33%) and smoking (30%). The most commonly reported reasons for use were insomnia (46%), pain (41%), and mood (39%). For the 164 health-care professionals who completed the survey (25% response rate), the majority agreed that cannabis use (72%) is safe and beneficial for patients (57%). Four in 10 (39%) health-care professionals felt comfortable providing guidance to patients about cannabis use; however, only 1 in 8 (13%) felt knowledgeable about the topic of cannabis.

Conclusions: Approximately one-sixth of patients with cancer receiving treatment actively use cannabis for management of various cancer symptoms. Perceptions about cannabis use and education varied widely among health-care professionals.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
对癌症患者和肿瘤科医护人员在治疗期间使用大麻情况的调查。
背景:本研究描述了国家癌症研究所指定癌症中心的患者和医护人员对医用大麻使用的看法。评估的数据包括大麻使用的流行率、模式和原因:作为国家癌症研究所资助的一项全国性工作的一部分,招募了正在接受治疗的癌症患者参与横断面调查。参与者填写了一份关于大麻使用情况、使用原因和大麻种类的调查表。此外,还进行了一项医疗保健专业人员调查,以了解他们对患者使用大麻的看法:2021 年至 2022 年期间,共有 313 名癌症患者(平均 [SD] 年龄 = 60.7 [12.8] 岁)完成了调查(回复率为 43%)。在受访者中,58% 为女性;61% 为白人,23% 为黑人;癌症诊断多种多样。近一半的受访者(43%)以前吸食过大麻,四分之一的受访者(26%)在确诊癌症后吸食过大麻,近六分之一的受访者(17%)在完成调查时正在积极吸食大麻。最常见的吸食方式是软糖(33%)和吸烟(30%)。最常报告的使用原因是失眠(46%)、疼痛(41%)和情绪(39%)。在完成调查的 164 名医护专业人员中(回复率为 25%),大多数人(72%)同意使用大麻是安全的,对病人有益(57%)。每 10 名医护人员中就有 4 人(39%)认为可以为患者提供有关使用大麻的指导;然而,每 8 人中只有 1 人(13%)认为自己了解大麻的相关知识:大约六分之一接受治疗的癌症患者积极使用大麻来控制各种癌症症状。医护人员对大麻使用和教育的看法差异很大。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
6.30
自引率
0.00%
发文量
0
期刊最新文献
Challenges to and considerations of designing cancer prevention trials. Design and analysis considerations for investigating patient subgroups of interest within cancer clinical trials. Design considerations and challenges in the CHinA National CancEr Screening (CHANCES) trial and Tomosynthesis Mammographic Imaging Screening Trial (TMIST). Global perspectives on patient-centered outcomes: advancing patient-centered cancer clinical trials globally. Intracluster correlation coefficients from cluster randomized trials conducted within the NCI Community Oncology Research Program (NCORP).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1